ZhenHealth Secures Nearly RMB 100 Million in Series B Funding to Advance Nationwide Eye Health Management Services

VCBeat learned at the first time,Recently, Beijing Zhizhen Internet Technology Co., Ltd. (hereinafter referred to as "Zhizhen Health") announced the completion of a new round of nearly 100 million yuan in B-round financing, jointly invested by Huaxia Hengtian Capital and Fuhuo Yongxin Venture Capital.

This is also the second round of financing completed by Zhizhen Health in 2021. In the first half of 2021, Zhizhen Health completed a multi-million-dollar A+ round of financing led by Xiran Capital, and at the same time, the C round of financing is also being prepared.

This round of financing will focus on expanding the medical services market and the research and development of smart hardware products, continuously optimizing and upgrading the core capabilities of AI algorithms. It will also expand the clinical application of AI software-hardware integrated solutions in tertiary hospitals and grassroots medical service institutions, accelerate implementation and coverage in scenarios such as education, insurance, elderly care, and chronic disease management, and comprehensively improve the eye health screening level across the entire medical system. Through "artificial intelligence + healthcare," it aims to achieve equitable distribution of medical resources and benefit a broader population.

Eye health involves the entire life cycle of people of all age groups. It is not only a component of individual physical and mental health but also regarded as an important part of national health. As of 2020, there were only 1.6 ophthalmologists per 50,000 people in China. Moreover, regional development is uneven, with doctors concentrated in developed areas, leading to a significant shortage of eye specialists in certain regions.

While the incidence of ophthalmic diseases is high, there is still a lack of awareness, low screening rates, and low treatment rates for eye health in China. Routine vision tests are often insufficient to detect eye conditions, and the key measures for treating many eye diseases and controlling their progression are "early screening, early diagnosis, and early treatment."

Zhizhen Health is a medical technology company focused on artificial intelligence eye health. It leverages technologies such as artificial intelligence, cloud computing, and big data, along with internet models and thinking, to integrate high-quality medical resources, achieve the interconnection of patients, medical institutions, and medicine, and create a combination of online and offline eye health products and services for the whole of China.

Against the backdrop of China's universal health, clinical healthcare faces issues such as uneven distribution of regional medical resources and slow progress in establishing tiered medical systems, resulting in many patients not being able to access high-quality medical services in a timely manner. Chronic disease management and eye health management have introduced diverse, long-tail demands for disease detection, prevention, health preservation, rehabilitation, and care. In response, Zhizhen Health has proposed two major product lines: in-hospital clinical healthcare and out-of-hospital health management.

The in-hospital clinical medical product line includes integrated in-hospital diagnosis and referral services, and a medical consortium health service platform., effectively integrating in-hospital department resources and out-of-hospital high-quality medical service resources respectively, promoting the equalization of resource supply.

Out-of-hospital Health Management Product Line Provides One-stop Health Assessment Solutions, helping users to automatically and independently detect, and issue personal eye health risk assessment reports for early screening, early diagnosis, and early treatment. The two major product lines jointly serve the H-end, B-end, and G-end markets.

In the future, Zhizhen Health will continue to focus on eye health management services for the entire population, striving to achieve the wonderful vision of "enabling people to have a pair of healthy eyes."

Mr. Guo Yongliang, Chairman of Huaxia Hengtian, said: AI is not meant to replace humans, but to better assist them in improving efficiency. Beyond "seeing and hearing," "understanding" is the most crucial ability, as it can continuously accumulate capabilities and gradually become an indefatigable expert in certain fields, unaffected by emotions! The three major advantages of Zhizhen Health far surpass those of its peers in the industry: first, a vast eye health database supported by tens of millions of fundus image data from hundreds of tertiary hospitals; second, strong technical accumulation and powerful computing capabilities in artificial intelligence provided by Baidu; third, clinical research and cooperation with dozens of tertiary hospitals across China, represented by Peking Union Medical College Hospital! It is believed that Zhizhen Health will go further and achieve greater success in this field!